by Queen Mary, University of London A gene has been discovered that can naturally suppress the signs of Alzheimer’s Disease in human brain cells, in research led by Queen Mary University of London. The scientists have also developed a new rapid drug-screening system for treatments that could potentially delay or prevent the disease. The main...
Children with COVID-19 may present with new neurological symptoms involving the central and peripheral nervous systems, and splenial changes on imaging, according to a study published online July 1 in JAMA Neurology. Omar Abdel-Mannan, M.D., from Great Ormond Street Hospital for Children in London, and colleagues reported neurological manifestations of children with COVID-19 in a...
by Newcastle University A regular dose of aspirin to reduce the risk of inherited bowel cancer lasts at least 10 years after stopping treatment, research has revealed. The international trial—known as CAPP2—involved patients with Lynch syndrome from around the world and revealed that two aspirins a day, for an average of two and a half...
by University of Nottingham Scientists from the University of Nottingham’s School of Psychology and School of Medicine used repetitive trains of stimulation to the median nerve (MNS) at the wrist to entrain rhythmic electrical brain activity—known as brain-oscillations—that are associated with the suppression of movements. They found that rhythmic MNS is sufficient to substantially reduce...
by Medical College of Georgia at Augusta University A group of tiny RNA that should attack the virus causing COVID-19 when it tries to infect the body are diminished with age and chronic health problems, a decrease that likely helps explain why older individuals and those with preexisting medical conditions are vulnerable populations, investigators report....
by E.j. Mundell, Healthday Reporter (HealthDay)—Studies are beginning to show that, in rare cases, people with severe COVID-19 may develop the serious nervous system disorder known as Guillain-Barre syndrome. “Guillain-Barre syndrome is a well-known condition in which one’s immune system targets peripheral nerves as foreign and attacks them, resulting in the cardinal features of the...
Supplements of the drug NAD+ may offer a new way of attacking Werner Syndrome, according to a study with animal models Patients with Werner Syndrome have early signs of aging, such as grey hair, wrinkled skin, and increased incidence of cancer and type 2 diabetes. On average, they die at the age of 45. The...
Sponsored Content by Bruker BioSpin – NMR, EPR and Imaging Guillain-Barre syndrome is a rare autoimmune condition in which the immune system attacks peripheral nerves and damages the myelin insulation. Symptoms rapidly progress from pain to muscle weakness and even paralysis. Although Guillain-Barre usually affects the hands, feet, and limbs, it can be life-threatening when...
Po-Cheng Hsu, M.D., from Taipei Veterans General Hospital in Taiwan, and colleagues used data from the Longitudinal Health Insurance Database 2015 from Taiwan’s National Health Insurance Research Database to examine the correlation between CTS and common autoimmune disorders (autoimmune rheumatic disease [ARD] and inflammatory bowel disease [IBD]). The researchers identified 3,291 ARD and IBD patients...
U by Kotex tampons recalled across the US and Canada after they started ‘unraveling’, getting stuck and causing women to seek medical attention to remove stray parts U by Kotex Sleek Tampons (Regular Absorbency) were launched in 2012 They were billed as a more ‘flexible’ upgrade to the standard On Tuesday, the company issued a...
